NO983776L - 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister - Google Patents
1,4-Dihydropyridin-forbindelser som Bradykinin-antagonisterInfo
- Publication number
- NO983776L NO983776L NO983776A NO983776A NO983776L NO 983776 L NO983776 L NO 983776L NO 983776 A NO983776 A NO 983776A NO 983776 A NO983776 A NO 983776A NO 983776 L NO983776 L NO 983776L
- Authority
- NO
- Norway
- Prior art keywords
- bradykinin
- octyl
- alkyl
- dihydropyridine compounds
- bradykinin antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9600132 | 1996-02-19 | ||
| PCT/IB1997/000058 WO1997030048A1 (en) | 1996-02-19 | 1997-01-27 | 1,4-dihydropyridine compounds as bradykinin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983776D0 NO983776D0 (no) | 1998-08-18 |
| NO983776L true NO983776L (no) | 1998-08-18 |
Family
ID=11004406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983776A NO983776L (no) | 1996-02-19 | 1998-08-18 | 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6131226A (de) |
| EP (1) | EP0882044B1 (de) |
| JP (1) | JP3167335B2 (de) |
| KR (1) | KR19990082678A (de) |
| CN (1) | CN1211251A (de) |
| AR (1) | AR005841A1 (de) |
| AT (1) | ATE220676T1 (de) |
| AU (1) | AU1396497A (de) |
| BG (1) | BG102678A (de) |
| BR (1) | BR9707568A (de) |
| CA (1) | CA2245857C (de) |
| CO (1) | CO4650041A1 (de) |
| CZ (1) | CZ258698A3 (de) |
| DE (1) | DE69714019T2 (de) |
| DK (1) | DK0882044T3 (de) |
| ES (1) | ES2177921T3 (de) |
| HN (1) | HN1997000013A (de) |
| HR (1) | HRP970094A2 (de) |
| HU (1) | HUP9902810A3 (de) |
| ID (1) | ID16434A (de) |
| IL (1) | IL124867A0 (de) |
| IS (1) | IS4783A (de) |
| MA (1) | MA26419A1 (de) |
| NO (1) | NO983776L (de) |
| NZ (1) | NZ325455A (de) |
| OA (1) | OA10712A (de) |
| PE (1) | PE36298A1 (de) |
| PL (1) | PL328514A1 (de) |
| PT (1) | PT882044E (de) |
| SI (1) | SI0882044T1 (de) |
| TN (1) | TNSN97037A1 (de) |
| TR (1) | TR199801593T2 (de) |
| WO (1) | WO1997030048A1 (de) |
| ZA (1) | ZA971357B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11106375A (ja) * | 1997-08-18 | 1999-04-20 | Pfizer Pharmaceut Inc | ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物 |
| EP1110962A1 (de) * | 1999-12-10 | 2001-06-27 | Pfizer Inc. | Verfahren zur herstellung von 1,4-dihydropyridine verbindungen |
| US6653313B2 (en) * | 2000-08-10 | 2003-11-25 | Warner-Lambert Company Llc | 1,4-dihydropyridine compounds as bradykinin antagonists |
| GB0427281D0 (en) * | 2004-12-14 | 2005-01-12 | 3M Innovative Properties Co | Methods of providing medicinal metal components having through holes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120750A (en) * | 1989-01-17 | 1992-06-09 | Synphar Laboratories, Inc. | Generation of 1,4-dihydropyridine derivatives |
| WO1996006083A1 (en) * | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| MX9701245A (es) * | 1996-02-19 | 1998-04-30 | Pfizer | Compuestos de 1,4 dihidropiridina. |
-
1996
- 1996-02-18 TN TNTNSN97037A patent/TNSN97037A1/fr unknown
-
1997
- 1997-01-27 US US09/125,137 patent/US6131226A/en not_active Expired - Fee Related
- 1997-01-27 AU AU13964/97A patent/AU1396497A/en not_active Abandoned
- 1997-01-27 HN HN1997000013A patent/HN1997000013A/es unknown
- 1997-01-27 HU HU9902810A patent/HUP9902810A3/hu unknown
- 1997-01-27 TR TR1998/01593T patent/TR199801593T2/xx unknown
- 1997-01-27 IL IL12486797A patent/IL124867A0/xx unknown
- 1997-01-27 CZ CZ982586A patent/CZ258698A3/cs unknown
- 1997-01-27 CN CN97192240A patent/CN1211251A/zh active Pending
- 1997-01-27 PT PT97900401T patent/PT882044E/pt unknown
- 1997-01-27 CA CA002245857A patent/CA2245857C/en not_active Expired - Fee Related
- 1997-01-27 AT AT97900401T patent/ATE220676T1/de not_active IP Right Cessation
- 1997-01-27 SI SI9730361T patent/SI0882044T1/xx unknown
- 1997-01-27 ES ES97900401T patent/ES2177921T3/es not_active Expired - Lifetime
- 1997-01-27 KR KR1019980706424A patent/KR19990082678A/ko not_active Ceased
- 1997-01-27 NZ NZ325455A patent/NZ325455A/xx unknown
- 1997-01-27 DK DK97900401T patent/DK0882044T3/da active
- 1997-01-27 DE DE69714019T patent/DE69714019T2/de not_active Expired - Fee Related
- 1997-01-27 EP EP97900401A patent/EP0882044B1/de not_active Expired - Lifetime
- 1997-01-27 BR BR9707568A patent/BR9707568A/pt active Search and Examination
- 1997-01-27 PL PL97328514A patent/PL328514A1/xx unknown
- 1997-01-27 WO PCT/IB1997/000058 patent/WO1997030048A1/en not_active Ceased
- 1997-01-27 JP JP52913897A patent/JP3167335B2/ja not_active Expired - Fee Related
- 1997-02-10 PE PE1997000085A patent/PE36298A1/es not_active Application Discontinuation
- 1997-02-13 CO CO97007547A patent/CO4650041A1/es unknown
- 1997-02-17 AR ARP970100614A patent/AR005841A1/es unknown
- 1997-02-18 ZA ZA971357A patent/ZA971357B/xx unknown
- 1997-02-18 ID IDP970467A patent/ID16434A/id unknown
- 1997-02-18 MA MA24498A patent/MA26419A1/fr unknown
- 1997-02-18 HR HRPCT/IB96/00132A patent/HRP970094A2/xx not_active Application Discontinuation
-
1998
- 1998-06-25 IS IS4783A patent/IS4783A/is unknown
- 1998-07-10 OA OA9800111A patent/OA10712A/en unknown
- 1998-08-10 BG BG102678A patent/BG102678A/xx unknown
- 1998-08-18 NO NO983776A patent/NO983776L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199801642T2 (xx) | Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri. | |
| NO990551L (no) | Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister | |
| NO20050417L (no) | Azaindol kinase-inhibitorer | |
| EP0948327A4 (de) | Antidiabetische mittel | |
| NO960393L (no) | Heterosykliske fenylforbindelser som COX-2-inhibitorer | |
| NO20074698L (no) | Pyrazinylsubstituerte piperazinpiperidiner med CXCR3-antagonistaktivitet | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
| BG100692A (en) | New heterocyclic compounds | |
| DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
| ES2149761T3 (es) | Derivado de piridazinona. | |
| FI905839A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi | |
| DE69108048D1 (de) | Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung. | |
| DE602004018617D1 (de) | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia | |
| TR200000671T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler. | |
| CA2221114A1 (en) | Atherosclerosis treatment | |
| CA2449402A1 (en) | Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| DE602004016123D1 (de) | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia | |
| NO983992L (no) | Serinprotease inhibitorer | |
| DE69831690D1 (de) | Stickstoffhaltige heterocyclische verbindungen, ihre herstellung und verwendung | |
| DE69229339D1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| ATE241360T1 (de) | Blutlipoproteinspiegel regulierendes präparat | |
| BR0210392A (pt) | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto | |
| NO973652L (no) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist |